Investor FAQs
Show All
Our corporate headquarters is located at: 12790 El Camino Real, Suite 200, San Diego, CA 92130. Our main telephone number is: (760) 593-4832.
The company is incorporated in Delaware.
Our initial public offering (IPO) occurred on October 21, 2021.
We are traded on the NASDAQ Global Select Market under the ticker symbol “VTYX”.
The company’s fiscal year end is December 31.
Ventyx Biosciences does not currently offer a direct stock purchase plan.
No
The company’s transfer agent is:
American Stock Transfer & Trust Company, LLC. The transfer agent and registrar’s address is 6201 15th Avenue, Brooklyn, New York 11219, and its telephone number is 718-921-8300.
American Stock Transfer & Trust Company, LLC. The transfer agent and registrar’s address is 6201 15th Avenue, Brooklyn, New York 11219, and its telephone number is 718-921-8300.
For questions about stock, please contact our transfer agent, American Stock Transfer & Trust Company, LLC.
The company’s independent auditors are Ernst & Young LLP.
The company’s legal counsel is Wilson Sonsini Goodrich & Rosati, P.C.
Please visit our website at: https://ventyxbio.com/.
The company’s news releases and financial reports can be viewed on the “Investors & News” tab of the company’s website at https://ventyxbio.com/.
The company’s SEC filings can be viewed under "SEC Filings" in the "Investors & News" section of our corporate website or www.sec.gov.
The company’s Executive Management team and Board of Directors can be viewed at https://ventyxbio.com/.
Please submit queries to our investor relations department by contacting: IR@ventyxbio.com.